Naohiko Ikegaki
Publications by Year
Research Areas
Neuroblastoma Research and Treatments, Cancer, Hypoxia, and Metabolism, Signaling Pathways in Disease, Virus-based gene therapy research, Cancer therapeutics and mechanisms
Most-Cited Works
- High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas.(2000)
- Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression.(2001)
- Resistance to chemotherapy mediated by TrkB in neuroblastomas.(2002)
- Expression of bcl-2 in small cell lung carcinoma cells.(1994)
- Characterization of the protein product of bcl-2, the gene involved in human follicular lymphoma.(1987)
- → Resistance to TRAIL-induced apoptosis in primitive neuroectodermal brain tumor cells correlates with a loss of caspase-8 expression(2000)175 cited
- → Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children’s Oncology Group study(2015)152 cited
- → Expression of TrkA, TrkB and TrkC in human neuroblastomas(1997)148 cited
- → Cloning and chromosomal localization of the human TRK-B tyrosine kinase receptor gene (NTRK2)(1995)104 cited
- → Expression of the Neurotrophin Receptor TrkB Is Associated With Unfavorable Outcome in Wilms’ Tumor(2001)102 cited